Company: NIVFW
Filing Date: 2025-06-03
Form Type: 424B3
Source: 0001213900-25-050825
Chunk: 5

Company: NewGenIvf Group Ltd
Filing Date: 2025-06-03
Form: 424B3
Chunk 5
---
” and the “Company” refer to NewGenIvf Group Limited and its wholly owned subsidiary, NewGenIvf
Limited, a Cayman Islands company.

Our reporting currency is
the U.S. dollar. Unless otherwise expressly stated or the context otherwise requires, references in this prospectus to “dollars”
or “$” are to U.S. dollars.

This prospectus includes statistical,
market and industry data and forecasts which we obtained from publicly available information and independent industry publications and
reports that we believe to be reliable sources. These publicly available industry publications and reports generally state that they obtain
their information from sources that they believe to be reliable, but they do not guarantee the accuracy or completeness of the information.
Although we believe that these sources are reliable, we have not independently verified the information contained in such publications.

Our consolidated financial
statements are prepared and presented in accordance with accounting principles generally accepted in the United States of America, or
U.S. GAAP.

The number of Class A Ordinary Shares and Class B Ordinary Shares currently
issued and outstanding was 1,050,840 as of June 2, 2025. No new shares are being issued by the Company pursuant to this offering.

<div align='center'>ii

ABOUT THIS PROSPECTUS</div>

This prospectus describes
the general manner in which the Selling Securityholders identified in this prospectus may offer from time to time up to 22,027,500 Class
A Ordinary Shares through any means described in the section entitled “Plan of Distribution.” You should rely only on the
information contained in this prospectus and the related exhibits, any prospectus supplement or amendment thereto and the documents incorporated
by reference, or to which we have referred you, before making your investment decision. Neither we nor the Selling Securityholders have
authorized anyone to provide you with different information. If anyone provides you with different or inconsistent information, you should
not rely on it. This prospectus, any prospectus supplement or amendments thereto do not constitute an offer to sell, or a solicitation
of an offer to purchase, the Resale Shares offered by this prospectus, any prospectus supplement or amendments thereto in any jurisdiction
to or from any person to whom or from whom it is unlawful to make such offer or solicitation of an offer in such jurisdiction. You should
not assume that the information contained in this prospectus, any prospectus supplement or amendments thereto, as well as information
we have previously filed with the U